COMMUNIQUÉS West-GlobeNewswire

Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)
07/10/2025
- First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications or adverse events reported to date - - Data from this non-MTS cohort, together with results [...]
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
07/10/2025
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/10/2025
VANCOUVER, British Columbia and BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, [...]
AAVantgarde announces 3 presentations at ESGCT 2025 annual meeting
07/10/2025
MILAN, Oct. 07, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced three presentations at the [...]
Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025
07/10/2025
Presentation of a comparison between digital and glass slide histology from screening biopsies in the Phase 3 NATiV3 study Presentation of digital pathology data from preclinical studies with lanifibranor Daix (France [...]
Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025
07/10/2025
Présentation d’une comparaison entre histologie numérique et sur lame des biopsies de screening de l’étude de Phase 3 NATiV3 Présentation de pathologie numérique de données précliniques avec lanifibranor Daix (France), [...]
NJ-Founded MetasTx Fast-Tracks Precision Approach to Stop Prostate Cancer Spread; NCI-Backed Diagnostic in Proof-of-Concept, Next-Gen KIT Inhibitor Advancing Toward First-in-Human
07/10/2025
PITTSBURGH, Oct. 07, 2025 (GLOBE NEWSWIRE) -- MetasTx, an early-stage biotech originally founded in New Jersey and now headquartered in Pittsburgh, announced progress on its two-part precision oncology platform designed [...]
Obesity Surgery Program Led by Dr. Mesut Caynak Expands Adoption of the ‘Caynak Technique’; SRC Master Accreditation Renewed
07/10/2025
Protocol-driven approach emphasizes system reliability, measured verification, and a 12-month structured follow-up to advance patient safety and outcomes Photo: Dr. Mesut Caynak ANTALYA, Turkey, Oct. 07, 2025 (GLOBE [...]
Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease
07/10/2025
Herantis Pharma announces positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease Trial meets all primary and secondary endpoints establishing a strong foundation to Phase 2 The [...]
Update: Checkerspot and Huvepharma Partner to Commercialize Groundbreaking Human Milk Fat Analog
07/10/2025
Clearing a Major Technological Hurdle, Checkerspot & Huvepharma Ready to Scale Production of the Novel, Direct Analog for Human Milk Fat Alameda, Calif (USA) and Sofia (Bulgaria), Oct. 07, 2025 (GLOBE NEWSWIRE) -- [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025
07/10/2025
Aggregated presentation by day and by market Statement of transactions in own shares from September 29th to October 03rd 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 40 - 2025
07/10/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 29 Septembre au 03 Octobre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
Ipsen - September 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
07/10/2025
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Septembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/10/2025
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Checkerspot and Huvepharma Partner to Commercialize Groundbreaking Human Milk Fat Analog
07/10/2025
Clearing a Major Technological Hurdle, Checkerspot & Huvepharma Ready to Scale Production of the Novel, Direct Analog for Human Milk Fat Alameda, Calif (USA) and Sofia (Bulgaria), Oct. 07, 2025 (GLOBE NEWSWIRE) -- [...]
NeXtGen Biologics Announces Issuance Of A Third New Patent Covering Axolotl-Derived Technology
07/10/2025
GAINESVILLE, Fla., Oct. 07, 2025 (GLOBE NEWSWIRE) -- NeXtGen Biologics announces the issuance of a third U.S. patent, US12311079, on May 27, 2025, as part of its suite of U.S. and foreign patents directed to [...]
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
07/10/2025
Comprehensive cognitive-support formula now available online; company scaling production for anticipated Q4 demand LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced [...]
Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population
07/10/2025
Primary endpoint was met in clinical study, demonstrating a comparable safety profile and a non-inferior immune response for MVA-BN in children aged 2-11 years compared to adults. Results will support filing for label [...]
Global Innovative Platforms Announces Completion of First Phase of Breath Test Study for Early Heartworm Detection
07/10/2025
New non-invasive diagnostic may identify heartworm months earlier than current methods MAITLAND, Fla., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Global Innovative Platforms Inc. (OTC: GIPL) today announced completion of the [...]

Pages